Teleflex (TFX) has quietly become a talking point after another choppy week for medtech names, with the stock drifting lower over the past week even as the past month’s performance turned positive.

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S. equity ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

After announcing plans to split up the company near the top of this year, Teleflex said it has found new homes for its businesses spanning acute care, urology and medical hardware manufacturing. Two ...

Have you evaluated the performance of Teleflex's (TFX) international operations for the quarter ending September 2025? Given the extensive global presence of this medical equipment maker, analyzing ...

Private equity firms Montagu and Kohlberg have announced plans to acquire Wayne, PA-based OEM Teleflex Medical for $1.5 billion in a carve-out transaction. Teleflex Medical OEM, which has been in ...

Teleflex's recent performance has been in line to slightly above expectations, but limited upside and better-valued med-tech alternatives make it hard to recommend owning TFX shares now. Growth ...

WAYNE, Pa., April 24, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the presentation of several clinical studies at the ...